Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional interactions between calmodulin and estrogen receptor-alpha.

Lu Li1, David B Sacks

  • 1Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, United States.

Cellular Signalling
|October 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproducibility of the diagnosis of diabetes by the 1-hour oral glucose tolerance test is substantial.

Diabetes research and clinical practice·2026
Same author

In Support of Venous Glucose as a Reference Matrix for Evaluating Continuous Glucose Monitoring Accuracy.

Journal of diabetes science and technology·2026
Same author

HbA1c underperforms in identifying abnormal glucose tolerance in the presence of G6PD deficiency: Insight from the Africans in America study.

PloS one·2026
Same author

KSR1 is a scaffold for the Hippo signaling pathway.

Communications biology·2025
Same author

Call for modification of the intermediate hyperglycemic classification of the 1 h-oral glucose tolerance test: insight from the Africans in America cohort Commentary.

Diabetes research and clinical practice·2025
Same author

The scaffold protein IQGAP1 regulates the epithelial Na<sup>+</sup> channel.

The Journal of biological chemistry·2025
Same journal

Diosgenin alleviates radiation nephropathy by suppressing renal mTORC1 signalling with concomitant effects on the gut and liver.

Cellular signalling·2026
Same journal

Glycine induces MafG to regulate glutathione metabolism, inhibit chondrocyte ferroptosis, and upregulate plectin to improve osteoarthritis.

Cellular signalling·2026
Same journal

SHC4 suppresses ferroptosis and promotes sorafenib resistance in hepatocellular carcinoma by disrupting the interaction between NCOA4 and FTH1.

Cellular signalling·2026
Same journal

Post-translational modifications in triple-negative breast cancer: research status and translation challenges.

Cellular signalling·2026
Same journal

PDK4-dependent lactate production and lactylation promote renal calcium oxalate crystal-induced EMT and mitochondrial dysfunction via the TGF-β/SMAD3/GPX4 axis.

Cellular signalling·2026
Same journal

O-GlcNAcylation-mediated glycolytic reprogramming of CD4<sup>+</sup> T cells contributes to type H vessel impairment in diabetic osteoporosis.

Cellular signalling·2026
See all related articles

Estrogen effects in breast cells involve estrogen receptors (ERalpha and ERbeta). This review explores how calcium and calmodulin impact ERalpha function, degradation, and gene activation in breast carcinoma.

Area of Science:

  • Molecular biology
  • Cell biology
  • Biochemistry

Background:

  • Estrogen receptor alpha (ERalpha) and estrogen receptor beta (ERbeta) mediate estrogen's effects in breast epithelial cells.
  • Calcium (Ca2+) and calmodulin are increasingly implicated in breast carcinoma development and ERalpha function.

Purpose of the Study:

  • To review recent findings on the role of Ca2+ and calmodulin in ERalpha modulation.
  • To propose molecular models explaining calmodulin's influence on ERalpha.

Main Methods:

  • Literature review of recent data.
  • Development of mechanistic models.

Main Results:

  • Calmodulin regulates both the degradation of ERalpha and its transcriptional activity.

Related Experiment Videos

  • Evidence suggests a significant role for Ca2+/calmodulin signaling in ERalpha-mediated processes.

    • Conclusions:

    • Calmodulin is a key regulator of ERalpha function in breast epithelial cells.
    • Understanding these mechanisms may offer insights into breast cancer therapies.